
|Articles|February 6, 2006
States sue over Part D Rx costs
Advertisement
At least five states will appeal directly to the U.S. Supreme Court to block the federal government from billing them for millions of dollars for drugs for former Medicaid patients switched to Medicare Part D plans. Although Congress had assured states that the change would lower their drug costs by 10%, the states contend that a flaw in the financial formula is leading the federal government to overcharge them.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Most Favored Nation, Direct-to-Consumer Strategies Reshape US Pharma Landscape, Challenging Traditional Care
2
A1c Monitoring Could Be Delayed Up to 2 Years for Patients With Type 2 Diabetes
3
Wicked Good Cardiometabolic Chat: SGLT2is Offer Cardiorenal Benefits Beyond Diabetes
4
Why It’s Crucial to Address Insulin Resistance During Pregnancy
5




















































































































































